Search Results for 'amputation'
5 results found.
REMEDI, The Regenerative Medicine Institute at NUI Galway and Orbsen Therapeutics have entered into an agreement with Cardium Therapeutics to utilise Cardium’s Excellagen® pharmaceutically-formulated gel as a delivery agent for Orbsen Therapeutics’ proprietary stromal cell therapy in pre-clinical studies for the potential treatment of diabetic foot ulcers.
Director of REMEDI, Professor Timothy O’Brien, is Head of Medicine at NUI Galway and a consultant endocrinologist at Galway University Hospital. REMEDI is one of Ireland’s top biomedical research institutes.
Fine Gael TD John O’Mahony has expressed his concern at the inadequate podiatry services available to people with diabetes in Mayo.
324 hospital admissions for diabetic foot disease in the Kilkenny area have cost the HSE South €9.72 million.
A Corrandulla man who was recently diagnosed with diabetes is calling on the HSE West to provide a foot screening programme and check-up service for sufferers in the region. The condition affects one in 20 people.